GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2941.8 and 2989.1
| Intraday Target 1 | 2904.83 |
| Intraday Target 2 | 2931.47 |
| Intraday Target 3 | 2952.1333333333 |
| Intraday Target 4 | 2978.77 |
| Intraday Target 5 | 2999.43 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 04 September 2026 | 2958.10 (0.7%) | 2938.90 | 2925.50 - 2972.80 | 0.4044 times | Thu 03 September 2026 | 2937.50 (-0.42%) | 2962.40 | 2930.40 - 2998.00 | 0.4708 times | Wed 02 September 2026 | 2949.90 (-1.54%) | 2972.60 | 2908.50 - 2990.10 | 0.4978 times | Tue 01 September 2026 | 2996.10 (-1.77%) | 3040.00 | 2966.40 - 3040.10 | 0.7553 times | Mon 31 August 2026 | 3050.10 (-1.81%) | 3106.50 | 3035.20 - 3120.00 | 1.7289 times | Fri 28 August 2026 | 3106.40 (1.22%) | 3069.00 | 3052.70 - 3120.70 | 1.1412 times | Thu 27 August 2026 | 3069.10 (1.14%) | 3030.00 | 3018.90 - 3118.00 | 1.9282 times | Wed 26 August 2026 | 3034.40 (2.4%) | 2995.00 | 2975.20 - 3049.90 | 0.9337 times | Tue 25 August 2026 | 2963.40 (1.08%) | 2953.80 | 2917.60 - 3010.00 | 1.4661 times | Mon 24 August 2026 | 2931.70 (1.02%) | 2875.10 | 2865.40 - 2955.90 | 0.6736 times | Fri 21 August 2026 | 2902.20 (-3.25%) | 2985.00 | 2880.00 - 2989.40 | 0.7278 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2827.55 and 3039.05
| Weekly Target 1 | 2784.03 |
| Weekly Target 2 | 2871.07 |
| Weekly Target 3 | 2995.5333333333 |
| Weekly Target 4 | 3082.57 |
| Weekly Target 5 | 3207.03 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 04 September 2026 | 2958.10 (-4.77%) | 3106.50 | 2908.50 - 3120.00 | 0.7413 times | Fri 28 August 2026 | 3106.40 (7.04%) | 2875.10 | 2865.40 - 3120.70 | 1.1805 times | Fri 21 August 2026 | 2902.20 (7.94%) | 2688.00 | 2660.00 - 3054.90 | 3.7596 times | Fri 14 August 2026 | 2688.80 (3.43%) | 2595.80 | 2576.10 - 2697.00 | 0.4561 times | Fri 07 August 2026 | 2599.70 (-2.1%) | 2665.40 | 2515.00 - 2684.00 | 0.51 times | Fri 31 July 2026 | 2655.40 (5.61%) | 2524.00 | 2494.10 - 2679.00 | 0.672 times | Fri 24 July 2026 | 2514.30 (2.42%) | 2454.50 | 2445.40 - 2570.00 | 0.5254 times | Fri 17 July 2026 | 2454.80 (0.68%) | 2439.90 | 2406.30 - 2527.00 | 0.6619 times | Fri 10 July 2026 | 2438.20 (1.78%) | 2390.20 | 2370.00 - 2460.80 | 0.4691 times | Fri 03 July 2026 | 2395.50 (1.73%) | 2347.80 | 2335.40 - 2504.70 | 1.0242 times | Thu 25 June 2026 | 2354.80 (0.98%) | 2358.10 | 2322.30 - 2404.80 | 0.7576 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2867.5 and 2999.1
| Monthly Target 1 | 2837.3 |
| Monthly Target 2 | 2897.7 |
| Monthly Target 3 | 2968.9 |
| Monthly Target 4 | 3029.3 |
| Monthly Target 5 | 3100.5 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 04 September 2026 | 2958.10 (-3.02%) | 3040.00 | 2908.50 - 3040.10 | 0.1373 times | Mon 31 August 2026 | 3050.10 (14.86%) | 2665.40 | 2515.00 - 3120.70 | 2.0937 times | Fri 31 July 2026 | 2655.40 (8.37%) | 2476.80 | 2370.00 - 2679.00 | 0.9192 times | Tue 30 June 2026 | 2450.30 (10.86%) | 2200.00 | 2088.10 - 2460.90 | 1.6521 times | Fri 29 May 2026 | 2210.20 (-5.4%) | 2342.00 | 2194.40 - 2520.00 | 1.1447 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.7051 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.5681 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.829 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.7405 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.2102 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.0094 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2523.1 and 3555.7
| Yearly Target 1 | 1689.7 |
| Yearly Target 2 | 2323.9 |
| Yearly Target 3 | 2722.3 |
| Yearly Target 4 | 3356.5 |
| Yearly Target 5 | 3754.9 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 04 September 2026 | 2958.10 (19.59%) | 2476.00 | 2088.10 - 3120.70 | 0.8525 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.482 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.1102 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.173 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.6813 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9088 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0142 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4339 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2207 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1234 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1237 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2952.46 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO is bearish. The stock has broken weekly support. An up move can be expected only after it starts trading above 2985.9
Munafa value: 60 as on Fri 04 September 2026
This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.
SMA20 is at 2885 and price is deviating by 166 points
Upper Bollinger band is at 3217 and lower is at 2553, while middle bands are at 2719 and 3051
Price is rising
Price is above 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term but the sell signal is initial and weak.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3019.95 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2978.34 |
| 12 day DMA | 2991.55 |
| 20 day DMA | 2884.55 |
| 35 day DMA | 2753.63 |
| 50 day DMA | 2657.69 |
| 100 day DMA | 2493.83 |
| 150 day DMA | 2484.46 |
| 200 day DMA | 2481.66 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2972.1 | 2979.1 | 2999.89 |
| 12 day EMA | 2952.46 | 2951.44 | 2953.97 |
| 20 day EMA | 2892.29 | 2885.37 | 2879.89 |
| 35 day EMA | 2784.16 | 2773.92 | 2764.29 |
| 50 day EMA | 2665.04 | 2653.08 | 2641.48 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2978.34 | 3008 | 3034.32 |
| 12 day SMA | 2991.55 | 2997.74 | 2992.73 |
| 20 day SMA | 2884.55 | 2866.63 | 2848.73 |
| 35 day SMA | 2753.63 | 2739.25 | 2726.93 |
| 50 day SMA | 2657.69 | 2645.63 | 2634.21 |
| 100 day SMA | 2493.83 | 2488.39 | 2482.95 |
| 150 day SMA | 2484.46 | 2480.96 | 2476.98 |
| 200 day SMA | 2481.66 | 2479.26 | 2477.05 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 61.15 and PE is: 48.37
Last quarter profit: (March 2026 quarter) 277.86 crores (5.70%)
Debt: 33.27 in crores
Market capitalization: 39891.73
EPS is 60.27 and PE is: 49.08
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


